Skip to main content

New Leader for The Sanford Project

Oct 25, 2015 04:09PM ● Published by MED Magazine

Sanford Health’s initiative to cure type 1 diabetes has chosen a world-renowned physician, 

 researcher and inventor as its new leader. Eckhard U. Alt, MD, PhD, has been appointed to oversee The Sanford Project as the Todd and Linda Broin Distinguished Professor and Chair.

 

Alt replaces Alex Rabinovitch, MD, who recently retired.

 

A global expert in regenerative medicine, Alt holds more than 650 patents in the field. He has authored more than 500 peer-reviewed journal articles, books and book chapters. In addition to leading The Sanford Project, Alt will retain his roles as professor of medicine at Technische Universität in Munich and professor at Tulane University. He will also continue to serve as chairman of the board for InGeneron, Inc., a company that develops cell-based technologies for healthcare and veterinary and life science research.

 

Alt received his medical degree from Heidelberg Medical School in Germany, where he was valedictorian. He completed additional training at Ludwig Maximilian University in Munich and Rechts der Isar Medical Center of the Technische Universität Munich.

 

Alt will lead a 20-member research team focusing on slowing the mechanisms that cause beta cells to die and leveraging the body’s natural ability to regenerate new beta cells through the use of stem cells. 

Today, News, People sanford

It looks like we don't have any events for this date. You can always add an event.

It looks like we don't have any events for this date. You can always add an event.

It looks like we don't have any events for this date. You can always add an event.

It looks like we don't have any events for this date. You can always add an event.

It looks like we don't have any events for this date. You can always add an event.

It looks like we don't have any events for this date. You can always add an event.

It looks like we don't have any events for this date. You can always add an event.

It looks like we don't have any events right now. You can always add an event.